These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 27197000)

  • 1. Clinical significance of pulse pressure in patients with heart failure with preserved left ventricular ejection fraction.
    Tokitsu T; Yamamoto E; Hirata Y; Kusaka H; Fujisue K; Sueta D; Sugamura K; Sakamoto K; Tsujita K; Kaikita K; Hokimoto S; Sugiyama S; Ogawa H
    Eur J Heart Fail; 2016 Nov; 18(11):1353-1361. PubMed ID: 27197000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of brachial-ankle pulse-wave velocity in patients with heart failure with preserved left ventricular ejection fraction.
    Tokitsu T; Yamamoto E; Oike F; Hirata Y; Tsujita K; Yamamuro M; Kaikita K; Hokimoto S
    J Hypertens; 2018 Mar; 36(3):560-568. PubMed ID: 29084082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Significance of Brachial-Ankle Pulse Wave Velocity in Patients With Heart Failure With Reduced Left Ventricular Ejection Fraction.
    Takae M; Yamamoto E; Tokitsu T; Oike F; Nishihara T; Fujisue K; Sueta D; Usuku H; Motozato K; Ito M; Kanazawa H; Araki S; Nakamura T; Arima Y; Takashio S; Suzuki S; Sakamoto K; Soejima H; Yamabe H; Kaikita K; Tsujita K
    Am J Hypertens; 2019 Jun; 32(7):657-667. PubMed ID: 31090886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined use of lung ultrasound, B-type natriuretic peptide, and echocardiography for outcome prediction in patients with acute HFrEF and HFpEF.
    Palazzuoli A; Ruocco G; Beltrami M; Nuti R; Cleland JG
    Clin Res Cardiol; 2018 Jul; 107(7):586-596. PubMed ID: 29532155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic importance of comorbidities in heart failure with preserved left ventricular ejection fraction.
    Maréchaux S; Six-Carpentier MM; Bouabdallaoui N; Montaigne D; Bauchart JJ; Mouquet F; Auffray JL; Le Tourneau T; Asseman P; LeJemtel TH; Ennezat PV
    Heart Vessels; 2011 May; 26(3):313-20. PubMed ID: 21063875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction.
    van Veldhuisen DJ; Linssen GC; Jaarsma T; van Gilst WH; Hoes AW; Tijssen JG; Paulus WJ; Voors AA; Hillege HL
    J Am Coll Cardiol; 2013 Apr; 61(14):1498-506. PubMed ID: 23500300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different relationships between pulse pressure and mortality in heart failure with reduced, mid-range and preserved ejection fraction.
    Teng TK; Tay WT; Dahlstrom U; Benson L; Lam CSP; Lund LH
    Int J Cardiol; 2018 Mar; 254():203-209. PubMed ID: 29407092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of high-sensitivity cardiac troponin in patients with heart failure with preserved ejection fraction.
    Suzuki S; Motoki H; Minamisawa M; Okuma Y; Shoin W; Okano T; Kimura K; Ebisawa S; Okada A; Kuwahara K
    Heart Vessels; 2019 Oct; 34(10):1650-1656. PubMed ID: 30929038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, Presentation, and Outcome of Heart Failure with Preserved Ejection Fraction among Patients Presenting with Undifferentiated Dyspnoea to the Emergency Room: A 10-year Analysis from a Tertiary Centre.
    Ruan W; Lim SH; Ding ZP; Sim DK; Gao F; Gunasegaran K; Kwok BW; Tan RS
    Ann Acad Med Singap; 2016 Jan; 45(1):18-26. PubMed ID: 27118225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of renal resistance index and arterial stiffness on clinical outcomes in patients with mild-to-moderate renal dysfunction and presence or absence of heart failure with preserved ejection fraction.
    Aizawa Y; Okumura Y; Saito Y; Ikeya Y; Nakai T; Arima K
    Heart Vessels; 2020 Dec; 35(12):1699-1708. PubMed ID: 32591893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of pulse wave velocity and central pulse pressure in heart failure with reduced ejection fraction.
    Kõre AC; Joonsalu T; Serg M; Pauklin P; Voitk J; Roose I; Eha J; Kampus P
    Blood Press; 2024 Dec; 33(1):2359932. PubMed ID: 38819846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposite predictive value of pulse pressure and aortic pulse wave velocity on heart failure with reduced left ventricular ejection fraction: insights from an Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) substudy.
    Regnault V; Lagrange J; Pizard A; Safar ME; Fay R; Pitt B; Challande P; Rossignol P; Zannad F; Lacolley P
    Hypertension; 2014 Jan; 63(1):105-11. PubMed ID: 24126172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Potassium and Cardiovascular Events in Heart Failure With Preserved Left Ventricular Ejection Fraction Patients.
    Nishihara T; Tokitsu T; Sueta D; Takae M; Oike F; Fujisue K; Usuku H; Takashio S; Hanatani S; Kanazawa H; Arima Y; Sakamoto K; Izumiya Y; Yamabe H; Kaikita K; Yamamoto E; Tsujita K
    Am J Hypertens; 2018 Sep; 31(10):1098-1105. PubMed ID: 29985986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High serum levels of thrombospondin-2 correlate with poor prognosis of patients with heart failure with preserved ejection fraction.
    Kimura Y; Izumiya Y; Hanatani S; Yamamoto E; Kusaka H; Tokitsu T; Takashio S; Sakamoto K; Tsujita K; Tanaka T; Yamamuro M; Kojima S; Tayama S; Kaikita K; Hokimoto S; Ogawa H
    Heart Vessels; 2016 Jan; 31(1):52-9. PubMed ID: 25150586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection Fraction　- Relevance to Age-Related Left Ventricular Modeling in Japanese.
    Harada E; Mizuno Y; Kugimiya F; Shono M; Maeda H; Yano N; Kuwahara K; Yasue H
    Circ J; 2017 Jun; 81(7):1006-1013. PubMed ID: 28381705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-Normal Serum Sodium and Heart Failure-Related Events in Patients With Heart Failure With Preserved Left Ventricular Ejection Fraction.
    Kusaka H; Sugiyama S; Yamamoto E; Akiyama E; Matsuzawa Y; Hirata Y; Fujisue K; Kurokawa H; Matsubara J; Sugamura K; Maeda H; Jinnouchi H; Matsui K; Ogawa H
    Circ J; 2016; 80(2):411-7. PubMed ID: 26632535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial Fibrosis, Functional Status, and Outcomes in Heart Failure With Preserved Ejection Fraction: Insights From a Prospective Cardiac Magnetic Resonance Imaging Study.
    Duca F; Kammerlander AA; Zotter-Tufaro C; Aschauer S; Schwaiger ML; Marzluf BA; Bonderman D; Mascherbauer J
    Circ Cardiovasc Imaging; 2016 Dec; 9(12):. PubMed ID: 27974408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brachial pulse pressure in acute heart failure. Results of the Heart Failure Registry.
    Bonapace S; Rossi A; Laroche C; Crespo-Leiro MG; Piepoli MF; Coats AJS; Dahlström U; Malek F; Macarie C; Temporelli PL; Maggioni AP; Tavazzi L;
    ESC Heart Fail; 2019 Dec; 6(6):1167-1177. PubMed ID: 31814303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incremental prognostic significance of the elevated levels of pentraxin 3 in patients with heart failure with normal left ventricular ejection fraction.
    Matsubara J; Sugiyama S; Nozaki T; Akiyama E; Matsuzawa Y; Kurokawa H; Maeda H; Fujisue K; Sugamura K; Yamamoto E; Matsui K; Jinnouchi H; Ogawa H
    J Am Heart Assoc; 2014 Jul; 3(4):. PubMed ID: 25012287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of serum triiodothyronine with B-type natriuretic peptide and severe left ventricular diastolic dysfunction in heart failure with preserved ejection fraction.
    Selvaraj S; Klein I; Danzi S; Akhter N; Bonow RO; Shah SJ
    Am J Cardiol; 2012 Jul; 110(2):234-9. PubMed ID: 22502900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.